Bebac user
☆    

Egypt,
2025-02-25 21:30
(135 d 13:23 ago)

Posting: # 24376
Views: 1,471
 

 Question about Williams Design [Design Issues]

Post reply
Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.
 
UA Flag
Activity
 Admin contact
23,432 posts in 4,931 threads, 1,671 registered users;
122 visitors (0 registered, 122 guests [including 61 identified bots]).
Forum time: 11:54 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5